3[1]Jean Chastre J, Fagon JV. Ventilator-associated pneumonia[J]. Am J Respir Crit Care Med, 2002, 165(7): 867-903.
4[2]Trouillet JL, Chaster J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria[J]. Am J Respir Care Med, 1998, 157(2): 531-539.
5[3]Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis[J]. Chest, 1992, 101(6): 1644-1655.
6[4]Legall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS Ⅱ) based on a european/north american multicenter study[J]. JAMA, 1993, 270(24): 2957-2963.
7[5]Wu CL, Yang DI, Wang NY, et al. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure[J]. Chest, 2002, 122(2): 662-668.
8Bauer TI', Tortes A, Ferrer R, et al. Biofilm formation in endotracheal tubes association between pneumonia and the persistence of pathogens. Monaldi Arch Chest Dis ,2002,57:84-87.
9Bhorade SM, Christenson J, Pohlman AS, et al. The incidence of and clin- ical variables associated with vancomycin-resistant enterococcal coloniza- tion in mechanically ventilated patients. Chest, 1999,115 : 1085-1091.
